Guru Ownership Trend
Guru Analysis for Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $560,838.32.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.92 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 89.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Aclaris Therapeutics, Inc. (ACRS)
Major holders include Renaissance Technologies (RenTech) ($435,591), Cliff Asness ($318,771). According to the latest reported data, 2 tracked investment managers collectively hold approximately 143,071 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.92 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ACRS. The total reported sell value was $3.92 M.
No tracked managers opened new positions or increased their holdings in ACRS during the most recent reporting period.